Free tool
Diagnostics stocks
We cover 7 companies grouped under the Diagnostics theme. The median market value in the group is $7.02M. Across the group, the median move over the past trading day is −1.38%. Price change over the past year runs from −98.3% to −25.2% across the middle 80 percent of the group, with a median of −79.2%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
7 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 0K3W.L | Myriad Genetics, Inc. | $370.48M | Small cap | −46.71% |
| N3B.F | Anbio Biotechnology | $356.84M | Small cap | −86.59% |
| CIZ.L | Cizzle Biotechnology Holdings Plc | $8.70M | Micro cap | +7.14% |
| VRCI.L | Verici Dx plc | $7.02M | Micro cap | −57.14% |
| VNRX | VolitionRx Limited | $5.25M | Micro cap | −97.21% |
| ADTX | Aditxt, Inc. | $2.59M | Micro cap | −100.00% |
| 2CUREX.ST | 2cureX AB (publ) | $1.75M | Micro cap | −79.23% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.